Factors influencing the antibody response of dogs vaccinated against rabies

Vaccine

Volumn 25, Issue 51, 2007, Pages 8500-8507

  Kennedy, Lorna J ^a   Lunt, Mark ^a   Barnes, Annette ^b   McElhinney, Lorraine ^c   Fooks, Anthony R ^c   Baxter, David N ^d   Ollier, William E R ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b UNIVERSITY OF LIVERPOOL   (United Kingdom)

^c VETERINARY LABORATORIES AGENCY   (United Kingdom)

^d Greater Manchester Health Protection Unit   (United Kingdom)

Author keywords

Dogs; FAVN; Pet travel scheme; Rabies; Vaccine

Indexed keywords

ANTIBODY; RABIES VACCINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ARTICLE; BREEDING; CONTROLLED STUDY; DOG; EMPORIATRICS; IMMUNITY; NONHUMAN; PET ANIMAL; PRIORITY JOURNAL; RABIES; REGRESSION ANALYSIS; SEROCONVERSION; STATISTICAL ANALYSIS; UNITED KINGDOM; VACCINATION;

AGING; ANIMALS; ANTIBODIES, VIRAL; COHORT STUDIES; DOG DISEASES; DOGS; FEMALE; HLA ANTIGENS; MALE; POLYMORPHISM, GENETIC; RABIES; RABIES VACCINES; REGRESSION ANALYSIS; SPECIES SPECIFICITY; TREATMENT FAILURE; VACCINATION;

EID: 36749099429     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2007.10.015     Document Type: Article

References (24)

1. Perrin P., Jacob Y., Aguilar-Setien A., Loza-Rubio E., Jallet C., Desmezieres E., et al. Immunization of dogs with a DNA vaccine induces protection against rabies virus. Vaccine 18 5-6 (1999) 479-486
2. Fooks A.R., McElhinney L.M., Brookes S.M., Johnson N., Keene V., Parsons G., et al. Rabies antibody testing and the UK pet travel scheme. Vet Rec 150 14 (2002) 428-430
3. Cliquet F., Aubert M., and Sagne L. Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody. J Immunol Meth 212 1 (1998) 79-87
4. Burr P.D., and Snodgrass D.R. Serological response to rabies vaccination for the pet travel scheme. Res Vet Sci 72 Suppl 1 (2002) 25
5. Ek-Kommonen C., Sihvonen L., Pekkanen K., Rikula U., and Nuotio L. Outbreak of canine distemper in vaccinated dogs in Finland. Vet Rec 141 15 (1997) 380-383
6. Tizard I.R., Vaccination, and Vaccines. Veterinary immunology. 5th ed. (1996), W.B. Saunders, London
7. Tjalve H. Adverse reactions to veterinary drugs reported in Sweden during 1991-1995. J Vet Pharmacol Ther 20 2 (1997) 105-110
8. Mansfield K.L., Burr P.D., Snodgrass D.R., Sayers R., and Fooks A.R. Factors affecting the serological response of dogs and cats to rabies vaccination. Vet Record 154 (2004) 423-426
9. Kennedy LJ, Davison LJ, Barnes A, Isherwood D, Ollier WER, Catchpole B. Susceptibility to canine diabetes mellitus is associated with MHC class II polymorphism. BSAVA annual congress 2003 scientific proceedings 2003. p. 593.
10. Kennedy L.J., Huson H.J., Leonard J., Angles J.M., Fox L.E., Wojciechowski J.W., et al. Association of Hypothyroid disease in Doberman Pinscher dogs with a rare Major Histocompatibility Complex DLA class II haplotype. Tissue Antigens 67 (2006) 53-56
11. Kennedy L.J., Quarmby S., Happ G.M., Barnes A., Ramsey I.K., Dixon R.M., et al. Association of canine Hypothyroidism with a common Major Histocompatibility Complex DLA class II allele. Tissue Antigens 68 (2006) 82-86
12. Ollier W.E.R., Kennedy L.J., Thomson W., Barnes A.N., Bell S.C., Bennett D., et al. Dog MHC alleles containing the "human RA shared epitope" confer susceptibility to canine rheumatoid arthritis. Immunogenetics 53 (2001) 669-673
13. Quinnell R.J., Kennedy L.J., Barnes A., Courtenay O., Dye C., Garcez L.M., et al. Susceptibility to visceral leishmaniasis in the domestic dog is associated with MHC class II polymorphism. Immunogenetics 55 1 (2003) 23-28
14. Fox J. Describing univariate distributions. In: Fox J., and Long J.S. (Eds). Modern methods of data analysis (1990), Sage Publications, Newbury Park, CA 58-125
15. In: Ellis R.W. (Ed). Hepatitis B vaccines in clinical practice (1993), Marcel Dekker
16. Keating G.M., and Noble S. Recombinant hepatitis B vaccine (Engerix-B): a review of its immunogenicity and protective efficacy against hepatitis B. Drugs 63 10 (2003) 1021-1051
17. Aspinall R. Longevity and the immune response. Biogerontology 1 3 (2000) 273-278
18. Tomer Y., and Shoenfeld Y. Ageing and autoantibodies. Autoimmunity 1 2 (1988) 141-149
19. Rupprecht C.E., Hanlon C.A., and Hemachudha T. Rabies re-examined. Lancet Infect Dis 2 6 (2002) 327-343
20. Wilsmore T, Hamblin C, Taylor N, Taylor W, Watson B. Qualitative veterinary risk assessment of the introduction or rabies into the United Kingdom. A report prepared for Defra (Department for the Environment, Food and Rural Affairs) 2006: http://www.defra.gov.uk/animalh/diseases/notifiable/rabies/pdf/qra-rabie s.pdf.
21. Eng T.R., and Fishbein D.B. Epidemiologic factors, clinical findings, and vaccination status of rabies in cats and dogs in the United States in 1988. National Study Group on Rabies. J Am Vet Med Assoc 197 2 (1990) 201-209
22. Kennedy L.J., Barnes A., Happ G.M., Quinnell R.J., Bennett D., Angles J.M., et al. Extensive interbreed, but minimal intrabreed, variation of DLA class II alleles and haplotypes in dogs. Tissue Antigens 59 3 (2002) 194-204
23. Kennedy L.J., Barnes A., Happ G.M., Quinnell R.J., Courtenay O., Carter S.D., et al. Evidence for extensive DLA polymorphism in different dog populations. Tissue Antigens 60 1 (2002) 43-52
24. Kennedy L.J., Carter S.D., Barnes A., Bell S., Bennett D., Ollier W.E.R., et al. Interbreed variation of DRB1, DQA1 alleles and haplotypes in the dog. Vet Immunol Immunopathol 69 (1999) 101-111